CJC-1295 (No DAC), Ipamorelin, GHRP-2 Blend is a multi-component research formulation containing three synthetic peptides used in controlled laboratory studies of growth hormone-axis receptor systems.
CJC-1295 without DAC is associated with growth hormone-releasing hormone receptor research. Ipamorelin and GHRP-2 are commonly examined in growth hormone secretagogue receptor type 1a models. Combining these materials provides laboratories with a standardized sample for studying multiple receptor-associated inputs within one defined experimental system.
References to growth hormone, pituitary, ghrelin, or endocrine signaling identify molecular pathways and laboratory models only. They do not indicate that the blend changes hormone concentrations, metabolism, body composition, physical performance, recovery, or any other outcome in humans or animals.
Lot-specific analytical documentation is available through the Nordsci Certificate of Analysis Library.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
CJC-1295 (No DAC), Ipamorelin, GHRP-2 Blend is a multi-component peptide research formulation supplied for controlled laboratory analysis of growth hormone-axis receptor systems. It combines one GHRH receptor-associated research peptide with two GHSR1a-associated research peptides.
Laboratories may use the blend in receptor-binding assays, cell-based signaling models, comparative compound studies, and time-dependent molecular-response experiments. Because the formulation contains three peptides, appropriate controls are required before an observed result can be associated with a specific component or receptor pathway.
References to growth hormone release, pulse patterns, pituitary responses, or endocrine communication describe experimental mechanisms. They do not indicate that the product changes growth hormone levels or produces physiological outcomes in humans or animals.
CJC-1295 (No DAC), Ipamorelin, GHRP-2 Blend – Research Specifications:
| Product Format | Multi-component peptide research blend |
| Contents | CJC-1295 without DAC, Ipamorelin, and GHRP-2 |
| Form | Lyophilized powder |
| Source | Chemical synthesis and compound-specific formulation |
| Purity / Identity | Refer to the lot-specific Certificate of Analysis |
| Analytical Documentation | Lot-specific documentation may report HPLC, mass spectrometry, or other applicable analytical results |
| Storage Conditions | Store sealed at −20°C or below and protect from light, heat, and moisture unless otherwise stated in the applicable documentation |
| Research Classification | Laboratory research and analytical use only |
| Restrictions | Not for human or animal consumption or in vivo, diagnostic, therapeutic, food, drug, cosmetic, or dietary-supplement use |
CJC-1295 without DAC is a synthetic GHRH-related research peptide. The absence of a Drug Affinity Complex distinguishes this material structurally from DAC-modified compounds and is relevant when establishing compound identity and experimental design.
Ipamorelin and GHRP-2 are synthetic growth hormone secretagogue research peptides commonly examined in models containing GHSR1a. Laboratory studies may measure receptor binding, receptor activation, second-messenger activity, or other predefined molecular endpoints.
Combining these three compounds allows researchers to examine multiple receptor-associated inputs within one standardized formulation. The blend may be compared with individual CJC-1295 without DAC, Ipamorelin, and GHRP-2 research arms.
A blended formulation does not independently identify which component is associated with a measured response. Compound-specific controls, consistent assay conditions, and validated analytical methods are necessary when individual pathway interpretation is required.
Important Research Notice: Nordsci research materials are supplied with access to lot-specific analytical documentation. Researchers should consult the applicable Certificate of Analysis for reported identity and purity information.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR LABORATORY RESEARCH. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR IN VIVO, DIAGNOSTIC, THERAPEUTIC, FOOD, DRUG, COSMETIC, OR DIETARY-SUPPLEMENT USE.
The blend may be evaluated in controlled cellular systems designed to represent specific GHRH receptor- and GHSR1a-associated signaling mechanisms. Applicable endpoints can include receptor activity, second-messenger measurements, and assay-specific molecular markers.
Observed activity remains specific to the selected in vitro model. It should not be interpreted as evidence that the blend changes growth hormone concentrations in humans or animals.
Researchers may use the blend in pituitary-derived or other endocrine-associated cellular models. These experiments can characterize molecular responses under defined concentration ranges, exposure periods, sampling intervals, and environmental conditions.
The use of pituitary-derived or endocrine-associated models identifies the experimental system. It does not indicate an effect on human or animal pituitary function or hormonal balance.
Laboratories may compare the blended formulation with individual CJC-1295 without DAC, Ipamorelin, or GHRP-2 research arms. This structure can help distinguish blended observations from compound-specific assay responses.
Any difference between study arms should be interpreted only within the limitations of the selected model, controls, methods, concentration ranges, and analytical endpoints.
Controlled laboratory experiments may measure receptor-associated markers across predefined timepoints. These studies can characterize assay timing and differences between test, vehicle, and comparator conditions.
Time-dependent molecular observations do not establish effects on circadian rhythms, sleep, metabolism, body composition, recovery, or other physiological outcomes.
The CJC-1295 (No DAC), Ipamorelin, GHRP-2 Blend should be handled only by qualified laboratory personnel using established procedures for multi-component peptide research materials. Laboratories should document product receipt, lot identification, storage conditions, sample allocation, testing methods, and disposal.
No reconstitution volume, diluent selection, concentration, dosing, injection, administration, or in vivo application guidance is provided.
Protocol Design Considerations:
Note: This information is provided exclusively as a laboratory research reference. All work should be conducted by qualified personnel in appropriately equipped facilities and in accordance with applicable institutional requirements.
Lot-specific Certificates of Analysis provide analytical information associated with the applicable blend. Documentation may include identity, purity, testing methodology, and other reported analytical results.
Researchers should confirm that the lot number on the vial corresponds with the lot number shown on the applicable COA. Analytical findings apply only to the tested lot and should not be interpreted as evidence of clinical safety, effectiveness, or approval for human or veterinary use.
Nordsci Peptides supplies CJC-1295 (No DAC), Ipamorelin, GHRP-2 Blend as a multi-component laboratory research material with access to lot-specific analytical documentation. Laboratories should evaluate formulation identity, reported analytical results, storage requirements, batch traceability, and institutional procurement standards before use.
IMPORTANT: This blend is sold exclusively for laboratory research and analytical use. It is not a drug, food, dietary supplement, cosmetic, or therapeutic product. It is not approved for human or veterinary use and must not be used for consumption, diagnosis, treatment, prevention, compounding, or any in vivo procedure.
